[1]祁桠楠a,胡江伟b,武　亮c,等.血清TLR-3，miR-181b及URBP联合检测在糖尿病肾病诊断及预后判断的价值研究[J].现代检验医学杂志,2022,37(02):37-41.[doi:10.3969/j.issn.1671-7414.2022.02.008]
　QI Ya-nana,HU Jiang-weib,WU Liangc,et al.Value of Combined Detection of Serum TLR-3, miR-181b and URBP in Diagnosis and Prognosis of Diabetic Nephropathy[J].Journal of Modern Laboratory Medicine,2022,37(02):37-41.[doi:10.3969/j.issn.1671-7414.2022.02.008]
点击复制

血清TLR-3，miR-181b及URBP联合检测在糖尿病肾病诊断及预后判断的价值研究()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第37卷
期数:
2022年02期
页码:
37-41
栏目:
论　著
出版日期:
2022-03-15

文章信息/Info

Title:
Value of Combined Detection of Serum TLR-3, miR-181b and URBP in Diagnosis and Prognosis of Diabetic Nephropathy
文章编号:
1671-7414（2022）02-037-05
作者:
祁桠楠a; 胡江伟b; 武　亮c; 高　倩b; 周雨聪c; 郑慧霄a
（邢台医学高等专科学校第二附属医院a. 体检中心;b. 内分泌科;c. 肾内科, 河北邢台 054000）
Author(s):
QI Ya-nana; HU Jiang-weib; WU Liangc; GAO Qianb; ZHOU Yu-congc; ZHEN Hui-xiaoa
（a.Physical Examination Center; b.Department of Endocrinology;c.Department of Nephrology, the Second Affiliated Hospital of Xingtai Medical College, Hebei Xingtai 054000,China）
关键词:
Toll样受体3; 微RNA-181b; 尿视黄醇结合蛋白; 糖尿病肾病; 终末期肾病
分类号:
R587.2；R392.11
DOI:
10.3969/j.issn.1671-7414.2022.02.008
文献标志码:
A
摘要:
目的　探讨Toll 样受体3（toll like receptor, TLR-3）、微RNA（micro RNA, miR）-181b 和尿视黄醇结合蛋白（urinary retinol binding-protein, URBP）联合检测在糖尿病肾病（DN）诊断及预后判断的价值。方法　选取2016 年12 月～ 2018年12 月邢台医学高等专科学校第二附属医院收治的115 例DN患者作为观察组，另选取同期96 例2 型糖尿病作为对照组。采用美国ABI 公司7900 实时荧光定量PCR 仪检测TLR-3，miR-181b 水平，采用BNP 特定蛋白分析仪以速率免疫散射比浊法检测URBP 水平，采用肾小管萎缩与间质纤维化（IFTA）、间质炎症和肾小球分级评分判断肾病理损伤程度，分析两组及观察组不同肾病理损伤程度患者血清TLR-3，miR-181b 及URBP 水平，分析上述指标与肾病理损伤相关性及对DN 的诊断价值，同时随访12 个月，分析上述指标与终末期肾病（end-stage renal disease, ESRD）的关系。结果　①观察组URBP（4.12±1.24mg/L），血清TLR-3（0.86±0.27）和miR-181b（2.55±0.76）水平高于对照组（2.88±0.86mg/L，0.59±0.18 和1.79±0.54），差异有统计学意义（t=8.367，8.217，8.275，均P ＜ 0.05）。② URBP，血清TLR-3，miR-181b 与DN 患者间质炎症、IFTA 评分和肾小球分级呈正相关（r=0.676，0.654，0.692，均P ＜ 0.05；r=0.705，0.682，0.733，均P ＜ 0.05；r=0.699，0.713 和0.745，均P ＜ 0.05）。③ URBP，血清TLR-3 和miR-181b 及三者联合诊断DN的曲线下面积（AUC）分别为0.751，0.782，0.796 和0.880。④ URBP 和miR-181b 高表达者随访12 个月ESRD 发生率（40.74%，41.03%）高于低表达者（9.52%，12.50%），差异有统计学意义（χ2=7.210，6.626，均P ＜ 0.05）。结论　URBP，血清TLR-3，miR-181b 与DN 患者肾脏病理损伤程度有关。三者联合可作为判定DN 的生物学标志物，指导临床防治ESRD。
Abstract:
Objective　To explore the value of combined detection of Toll like receptor 3 (TLR-3), micro RNA (miR)-181b and urinary retinol binding protein (URBP) in the diagnosis and prognosis of diabetic nephropathy (DN). Methods　From December 2016 to December 2018, 115 patients with DN admitted to the Second Affiliated Hospital of Xingtai Medical College were selected as the observation group, and the other 96 cases of type 2 diabetes mellitus were selected as the control group. The levels of TLR-3 and miR-181b were detected by ABI 7900 real-time quantitative PCR, and the levels of URBP were detected by BNP specific protein analyzer. The levels of serum TLR-3, miR-181b and URBP in the two groups and the observation group with different degrees of renal pathological damage glomerular grading, renal tubular atrophy and interstitial fibrosis (IFTA) score, interstitial inflammation were analyzed. The correlation between the above indexes and renal pathological injury and the diagnostic value of DN were analyzed. The patients were followed up for 12 months to analyze the relationship between the above indexes and end-stage renal disease (ESRD). Results　① The levels of URBP (4.12±1.24mg/L) and serum TLR-3 (0.86± 0.27), miR-181b (2.55±0.76) of the observation group were higher than those of the control group (2.88±0.86mg/L ,0.59±0.18 and 1.79±0.54), the differences were statistically significant(t=8.367, 8.217 ，8.275, all P ＜ 0.05). ② URBP (r=0.676, 0.654，0.692, all P<0.05) and serum TLR-3 (r=0.705, 0.682, 0.733, all P<0.05), miR-181b ( r=0.699, 0.713, 0.745, all P<0.05) was positively correlated with interstitial inflammation, IFTA score, and glomerular grading in DN patients. ③ The area under the curve (AUC) of URBP, serum TLR-3 and miR-181b in alone and combined diagnosis of DN were 0.753, 0.782 and 0.880, respectively. ④The incidence of ESRD ( 40.74%, 41.03%) of high-expressing URBP and miR-181b was higher than that of low-expressing people during the 12-month follow-up (9.52%, 12.50%), the differences were statistically significant(χ2=7.210, 6.626, all P ＜ 0.05). Conclusion　URBP, serum TLR-3 and mir-181b were related to the degree of renal pathological injury in patients with DN. The combination of the three can be used as a biomarker to determine DN and guide the clinical prevention and treatment of ESRD.

参考文献/References:

[1] HOCHER B, TSUPRYKOV O. Diabetic nephropathy: Renoprotective effects of GLP1R agonists and SGLT2 inhibitors[J]. Nature Reviews Nephrology, 2017, 13(12): 728-730.
[2] 张曙晴, 张骆军, 李洪彬, 等. 血液小而密低密度脂 蛋白胆固醇、抗凝血酶Ⅲ水平及血小板参数检测在 2 型糖尿病肾病中的应用价值研究[J]. 现代检验医 学杂志, 2021,36 (2): 70-74,97. ZHANG Shuqing, ZHANG Luojun, LI Hongbin, et al. Study on the application value of detecting small dense low-density lipoprotein cholesterol,antithrombin- Ⅲ levels and platelet parameter in the patients with type-2 diabetic nephropathy [J]. Journal of Modern Laboratory Medicine , 2021,36 (2): 70-74,97.
[3] 宋凯云, 刘必成, 汤日宁．内皮- 足细胞对话在糖 尿病肾病中的研究进展[J]．中华肾脏病杂志, 2019, 35（3）：231-235． SONG Kaiyun, LIU Bingcheng, TANG Rining. Advances in research of endothelial-podocyte crosstalk in diabetic kidney disease [J]. Chinese Journal of Nephrology,2019,35 (3):231-235.
[4] 李鑫, 范秋灵, 汪旭, 等.2 型糖尿病和糖尿病肾病 患者血清微小RNA-148b-3p 的水平变化及意义[J]. 中华肾脏病杂志, 2018, 34(5):348-354. LI Xin,FAN Qiuling,WANG Xu,et al. Change and clinical significance of microRNA-148b-3p level in the serum of patients with type 2 diabetes mellitus and diabetic nephropathy[J]. Chinese Journal of Nephrology,2018,34 (5):348-354.
[5] ZHU Fuxiang, WU Henglan, CHEN Jianxiang, et al. Dysregulation of microRNA-181b and TIMP3 is functionally involved in the pathogenesis of diabetic nephropathy[J]. Journal of Cellular Physiology, 2019, 234(10): 18963-18969.
[6] GONG Lina, YANG Pu, HU Ling, et al. MiR-181b suppresses the progression of epilepsy by regulation of lncRNA ZNF883[J]. American Journal of Translational Research, 2020, 12(6): 2769-2780.
[7] 中华医学会内分泌学分会. 中国成人糖尿病肾脏 病临床诊断的专家共识[J]. 中华内分泌代谢杂志, 2015, 31(5):379-385. Chinese Society of Endocrinology of Chinese Medical Association. Expert consensus on clinical diagnosis of diabetic nephropathy in Chinese adults[J]. Chinese Journal of Endocrinology and Metabolism,2015,31 (5):379-385.
[8] SIU A L, U S Preventive Services Task Force. Screening for abnormal blood glucose and type 2 diabetes mellitus: U.S. Preventive Services Task Force Recommendation Statement. [J]. Annals of Internal Medicine, 2015, 163(11): 861-868.
[9] 韩晨鹏, 徐清芳, 张美华, 等.2 型糖尿病患者血清 抵抗素、VEGF、糖化白蛋白联合检测在糖尿病肾 病早期诊断中的价值分析[J]. 分子诊断与治疗杂志, 2019,11 (2):128-131, 151. HAN Chenpeng,XU Qingfang,ZHANG Meihua,et al. The evaluation of combined detection of serum resistin, VEGF and glycated albumin in early diagnosis of diabetic nephropathy in patients with type 2 diabetes[J]. Journal of Molecular Diagnosis and Therapy ,2019,11 (2):128-131, 151.
[10] 刘虹, 毛敏, 王晓敏, 等.microRNA-181b 在慢性淋 巴细胞白血病患者中的表达及其预后意义[J]. 中华 全科医学,2018,16 (11):1779-1783. LIU Hong, MAO Min, WANG Xiaomin,et al. Expression level and prognosis significance of microRNA- 181b in patients with chronic lymphocytic leukemia [J]. Chinese Journal of General Practice,2018,16 (11):1779-1783.
[11] 贺白, 朱丹霞, 晁红颖．miR-181b 在弥漫大B 细 胞淋巴瘤中表达及功能研究[J]. 中国实验血液学杂 志,2018,26 (4):1111-1115. HE Bai,ZHU Danxia,CHAO Hongying. Expression and function of miR-181b in diffuse large B cell lymphoma [J].Journal of Experimental Hematology,2018,26 (4):1111-1115.
[12] 王琳琳, 冯佳莉, 刘俊芬, 等.2 型糖尿病和糖尿病 肾病患者血清miR-181b 水平及意义[J]. 实用医学杂 志,2019,35 (18):2853-2856. WANG Linlin,FENG Jianli,LIU Junfen,et al. Serum miR-181b level and significance in patients with type 2 diabetes and diabetic nephropathy [J]. The Journal of Practical Medicine,2019,35 (18):2853-2856.
[13] 王家芷, 王成, 寿岚. 血清miR-130b 与糖尿病肾病 患者肾脏损伤及远期预后的相关性研究[J]. 中国中 西医结合肾病杂志, 2019, 20(4):316-318. WANG Jiazhi, WANG Cheng, SHOU Lan. Correlation of serum miR-130b with renal injury and long-term prognosis in patients with diabetic nephropathy [J]. Chinese Journal of Integrated Traditional and Western Nephrology,2019,20(4):316-318.
[14] WANG Hanqing, WANG Shasha, CHIUFAI K, et al. Umbelliferone ameliorates renal function in diabetic nephropathy rats through regulating inflammation and TLR/NF-κB pathway [J]. Chinese Journal of Natural Medicines, 2019, 17(5): 346-354.
[15] TSAI Y L, LIU C W, HUANG S F, et al. Urinary fatty acid and retinol binding protein-4 predict CKD progression in severe NAFLD patients with hypertension: 4-year study with clinical and experimental approaches[ J]. Medicine, 2020, 99(2): e18626.
[16] 曾福英, 蒋伟勇, 张秋梅.RBP, Cys C,sICAM-1,u- MALB 联合检测对早期糖尿病肾病的诊断价值 RBP,CysC,sICAM-1,u-MALB 联合检测对早期糖尿 病肾病的诊断价值[J]. 热带医学杂志,2019,19 (1): 35-38. ZENG Fuying,JIANG Weiyong,ZHANG Qiumei. Diagnostic value of combined detection of RBP, Cys C, sICAM-1 and u-MALB in early diabetic nephropathy[J]. Journal of Tropical Medicine,2019,19 (1):35-38.
[18] 杨宏秀, 刘丽, 张会芬, 等. 血清抗中性粒细胞胞浆 抗体及相关炎性因子检测对糖尿病肾病的诊断价值 [J]．现代检验医学杂志, 2018,33 (5): 95-97,101. YANG Hongxiu, LIU Li, ZHANG Huifen, et al. Diagnostic value of detection anti-cardiolipin antibodies and related inflammatory factors in diabetic nephropathy [J]. Journal of Modern Laboratory Medicine, 2018,33 (5): 95-97,101.

备注/Memo

备注/Memo:
基金项目：邢台市科技支撑计划项目（2018ZC177）。
作者简介：祁桠楠（1983-），女，本科，学士，主治医师，主要从事全科医学工作，研究方向：肾脏病诊治，E-mail:qiyanan319@sina.com。
通讯作者：郑慧霄（1966-），女，本科，学士，主任医师，研究方向：肾脏病诊治。
更新日期/Last Update: 1900-01-01